Phase 1 study of human plasma-derived plasmin (TAL-05-00018) in hemodialysis graft occlusion

Thrombosis Research

Volumn 122, Issue SUPPL. 3, 2008, Pages

  Shlansky Goldberg, Richard ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIBIOTIC AGENT; FIBRINOGEN; HEPARIN; PLASMIN; TAL 05 00018; UNCLASSIFIED DRUG;

ADULT; AGED; ANASTOMOSIS; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FISTULOGRAPHY; GRAFT OCCLUSION; HEMODIALYSIS; HUMAN; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PUSTULE; RASH;

FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; PLASMIN; RENAL DIALYSIS;

EID: 50849107680     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.06.020     Document Type: Article

References (12)

1. Bookstein J.J., Fellmeth B., Roberts A., et al. Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR Am J Roentgenol 152 (1989) 1097-1100
2. Valji K. Transcatheter treatment of thrombosed hemodialysis access grafts. AJR Am J Roentgenol 164 (1995) 823-829
3. Sofocleous C.T., Hinrichs C.R., Weiss S.H., et al. Alteplase for hemodialysis access graft thrombolysis. J Vasc Interv Radiol 13 (2002) 775-784
4. Marder V.J., and Stewart D. Towards safer thrombolytic therapy. Semin Hematol 39 (2002) 206-216
5. Marder V.J. The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med 90 (1979) 802-808
6. Dotter C.T., Rösch J., and Seaman A.J. Selective clot lysis with low-dose streptokinase. Radiology 111 (1974) 31-37
7. Ouriel K., Gray B., Clair D.G., and Olin J. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 11 (2000) 295-298
8. Henkin J., Marcotte P., and Yang H.C. The plasminogen-plasmin system. Prog Cardiovasc Dis 34 (1991) 135-164
9. Wiman B., Lijnen H.R., and Collen D. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. Biochim Biophys Acta 579 (1979) 142-154
10. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 43 (1980) 77-89
11. Middlebrook M.R., Amygdalos M.A., Soulen M.C., et al. Thrombosed hemodialysis grafts: percutaneous mechanical balloon declotting versus thrombolysis. Radiology 196 (1995) 73-77
12. R.D. Shlansky-Goldberg, A.H. Matsumoto, G.A. Baumbach, et al. A first-in-human phase 1 trial of locally-delivered human plasmin for hemodialysis graft occlusion. J Thromb Haemost 2008, Apr 2 [Electronic publication ahead of print] in press.